Novo Nordisk Warns of Revenue Decline as Pricing Pressure Hits Weight-Loss Drugs by USA Weekly Today Editorial Team September 26, 2026 Novo Nordisk, the maker of Wegovy and Ozempic, has forecast a sharp fall in revenue for … Read more
